Average Co-Inventor Count = 2.35
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Synthetic Biologics, Inc. (19 from 37 patents)
2. Theriva Biologics, Inc. (6 from 11 patents)
3. Synthetic Biologies, Inc. (3 from 4 patents)
4. Novartis Ag (1 from 3,923 patents)
5. Genetic Therapy, Inc. (1 from 16 patents)
6. Genetic Theraphy, Inc. (1 from 1 patent)
7. Memorial Sloan Kettering Cancer Center (559 patents)
31 patents:
1. 12274740 - Microbiome protection from oral antibiotics
2. 12178917 - Beta-lactamase formulations and uses thereof
3. 11944669 - Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
4. 11883474 - Microbiome protection from oral antibiotics
5. 11654184 - Alkaline phosphatase agents for treatment of radiation disorders
6. 11608494 - Beta-lactamases with improved properties for therapy
7. 11596674 - Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
8. 11517614 - Microbiome protection from oral antibiotics
9. 11338020 - Alkaline phosphatase agents for treatment of neurodevelopmental disorders
10. 11236319 - Beta-lactamases with improved properties for therapy
11. 11123413 - Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
12. 10828260 - Beta-lactamase formulations and uses thereof
13. 10792346 - Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
14. 10767171 - Beta-lactamases with improved properties for therapy
15. 10584326 - Beta-lactamases with improved properties for therapy